| Dr Olumide Anuoluwa Omiwade, MBCHB | |
|
2251 N Shore Dr Ste 100, Rhinelander, WI 54501-6710 | |
| (713) 550-7718 | |
| Not Available |
| Full Name | Dr Olumide Anuoluwa Omiwade |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 2251 N Shore Dr Ste 100, Rhinelander, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427210699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 55799620 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Marys Hospital | Rhinelander, WI | Hospital |
| Aspirus Ironwood Hospital | Ironwood, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
| Entity Name | Aspirus Merrill Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124084678 PECOS PAC ID: 0143117556 Enrollment ID: O20040301001179 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
| Entity Name | Aspirus Eagle River Hospital & Clinics, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346204385 PECOS PAC ID: 1658361951 Enrollment ID: O20040518000233 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Olumide Anuoluwa Omiwade, MBCHB 2251 N Shore Dr Ste 100, Rhinelander, WI 54501-6710 Ph: (713) 550-7718 | Dr Olumide Anuoluwa Omiwade, MBCHB 2251 N Shore Dr Ste 100, Rhinelander, WI 54501-6710 Ph: (713) 550-7718 |
News Archive
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return. The ability of many brain tumors to regenerate can be traced to cancer stem cells that evade treatment and spur the growth of new tumor cells.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
Rates of anxiety and depression among college students in the U.S. have risen rapidly in the past decade. Students are showing up at college counseling centers only to discover they often must wait weeks and even months to see a mental health expert. In response, New Directions Behavioral Health® (New Directions) announced the launch of its Student Assistance Program to support and expand existing campus counseling services and resources.
› Verified 5 days ago
William Eugene Wright, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-4700 | |
Jerome C Andres, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1630 Chippewa Dr, Rhinelander, WI 54501 Phone: 715-361-5480 Fax: 715-365-5258 | |
Heather L Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1630 North Chippewa Dr, Rhinelander, WI 54501 Phone: 715-361-5480 | |
Russell S Sudbury, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-4700 | |
Amy J H Ewan, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1630 N Chippewa Dr, Rhinelander, WI 54501 Phone: 715-361-5480 Fax: 715-361-5499 | |
Dr. James R Smith, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1630 Chippewa Dr, Rhinelander, WI 54501 Phone: 715-361-5480 Fax: 715-361-5499 |